• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过金属亲和膜色谱法快速纯化重组登革热病毒和西尼罗河病毒包膜结构域III蛋白

Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography.

作者信息

Tan Lik Chern Melvin, Chua Anthony Jin Shun, Goh Li Shan Liza, Pua Shu Min, Cheong Yuen Kuen, Ng Mah Lee

机构信息

Flavivirology Laboratory, Department of Microbiology, 5 Science Drive 2, National University of Singapore, Singapore 117597, Singapore.

出版信息

Protein Expr Purif. 2010 Nov;74(1):129-37. doi: 10.1016/j.pep.2010.06.015. Epub 2010 Jul 1.

DOI:10.1016/j.pep.2010.06.015
PMID:20600950
Abstract

Arthropod-borne flaviviruses such as dengue virus (DENV) and West Nile virus (WNV) pose significant health threats to the global community. Due to escalating numbers of DENV and WNV infections worldwide, development of an effective vaccine remains a global health priority. As flavivirus envelope Domain III (DIII) protein is highly immunogenic and capable of inducing neutralizing antibodies against wild-type virus, it is both a potential protein subunit vaccine candidate and a suitable diagnostic reagent. Here, we describe the use of metal affinity membrane chromatography as a rapid and improved alternative for the purification of recombinant DIII (rDIII) antigens from DENV serotypes 1-4 and WNV - New York, Sarafend, Wengler and Kunjin strains. Optimum conditions for the expression, solubilization, renaturation and purification of these proteins were established. The purified proteins were confirmed by MALDI-TOF mass spectrometry and ELISA using antibodies raised against the respective viruses. Biological function of the purified rDIII proteins was confirmed by their ability to generate DIII-specific antibodies in mice that could neutralize the virus.

摘要

节肢动物传播的黄病毒,如登革病毒(DENV)和西尼罗河病毒(WNV),对全球社区构成重大健康威胁。由于全球范围内DENV和WNV感染数量不断增加,开发有效的疫苗仍然是全球卫生的优先事项。由于黄病毒包膜结构域III(DIII)蛋白具有高度免疫原性,能够诱导针对野生型病毒的中和抗体,它既是一种潜在的蛋白亚单位疫苗候选物,也是一种合适的诊断试剂。在此,我们描述了使用金属亲和膜色谱法作为一种快速且改进的替代方法,用于从DENV血清型1-4以及WNV的纽约株、萨拉芬德株、温格勒株和库京株中纯化重组DIII(rDIII)抗原。确定了这些蛋白表达、溶解、复性和纯化的最佳条件。通过基质辅助激光解吸电离飞行时间质谱(MALDI-TOF)和使用针对相应病毒产生的抗体进行的酶联免疫吸附测定(ELISA)对纯化的蛋白进行了确认。纯化的rDIII蛋白的生物学功能通过其在小鼠体内产生能够中和病毒的DIII特异性抗体的能力得到证实。

相似文献

1
Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography.通过金属亲和膜色谱法快速纯化重组登革热病毒和西尼罗河病毒包膜结构域III蛋白
Protein Expr Purif. 2010 Nov;74(1):129-37. doi: 10.1016/j.pep.2010.06.015. Epub 2010 Jul 1.
2
High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli.重组登革2型病毒包膜结构域III蛋白在大肠杆菌中的高效表达及一步纯化
Protein Expr Purif. 2004 Jan;33(1):80-91. doi: 10.1016/j.pep.2003.09.009.
3
A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.一种编码西尼罗河病毒 E 蛋白的 DNA 疫苗具有保护作用,并且可以通过重组结构域 DIII 进行加强。
Vaccine. 2011 Aug 26;29(37):6352-7. doi: 10.1016/j.vaccine.2011.04.116. Epub 2011 May 17.
4
High-level expression of recombinant dengue virus type 2 envelope domain III protein and induction of neutralizing antibodies in BALB/C mice.重组登革2型病毒包膜结构域III蛋白在BALB/C小鼠中的高效表达及中和抗体的诱导
J Virol Methods. 2007 Aug;143(2):125-31. doi: 10.1016/j.jviromet.2007.02.012. Epub 2007 May 29.
5
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.植物源疫苗可预防小鼠感染致死性西尼罗河病毒,而不增强寨卡病毒或登革热病毒的感染力。
Vaccine. 2018 Mar 27;36(14):1846-1852. doi: 10.1016/j.vaccine.2018.02.073. Epub 2018 Feb 26.
6
Cross protection against lethal West Nile virus challenge in mice immunized with recombinant E protein domain III of Japanese encephalitis virus.用重组日本脑炎病毒 E 蛋白结构域 III 免疫的小鼠对致死性西尼罗河病毒攻击的交叉保护作用。
Immunol Lett. 2011 Aug 30;138(2):156-60. doi: 10.1016/j.imlet.2011.04.003. Epub 2011 Apr 14.
7
An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.一种编码基于包膜结构域III的四价抗原的5型腺病毒(AdV5)载体,在预先存在AdV5免疫的情况下,能引发针对所有四种登革病毒的免疫反应。
Vaccine. 2009 Oct 9;27(43):6011-21. doi: 10.1016/j.vaccine.2009.07.073. Epub 2009 Aug 7.
8
A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines.西尼罗河病毒 CD4 T 细胞表位可提高登革热病毒血清型 2 疫苗的免疫原性。
Virology. 2012 Mar 15;424(2):129-37. doi: 10.1016/j.virol.2011.12.012. Epub 2012 Jan 14.
9
Induction of neutralizing antibodies specific to dengue virus serotypes 2 and 4 by a bivalent antigen composed of linked envelope domains III of these two serotypes.由这两种血清型的连接包膜结构域III组成的二价抗原诱导针对登革病毒2型和4型的中和抗体。
Am J Trop Med Hyg. 2006 Feb;74(2):266-77.
10
Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection.西尼罗河病毒重组包膜结构域III蛋白免疫可诱导特异性免疫反应并提供针对西尼罗河病毒感染的保护。
J Immunol. 2007 Mar 1;178(5):2699-705. doi: 10.4049/jimmunol.178.5.2699.

引用本文的文献

1
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants.与含QS21的陆军脂质体制剂(ALFQ)联合产生的未糖基化可溶性严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域(RBD)可引发针对不匹配变体的中和抗体。
Vaccines (Basel). 2022 Dec 25;11(1):42. doi: 10.3390/vaccines11010042.
2
Recent development and application of membrane chromatography.膜色谱技术的最新发展与应用。
Anal Bioanal Chem. 2023 Jan;415(1):45-65. doi: 10.1007/s00216-022-04325-8. Epub 2022 Sep 21.
3
COVID-19 vaccine platforms: Delivering on a promise?
COVID-19 疫苗平台:兑现承诺?
Hum Vaccin Immunother. 2021 Sep 2;17(9):2873-2893. doi: 10.1080/21645515.2021.1911204. Epub 2021 May 25.
4
Evaluation of antibody response against recombinant domain III proteins of dengue virus type 1 and 2.针对1型和2型登革病毒重组结构域III蛋白的抗体反应评估。
AIMS Microbiol. 2017 Apr 14;3(2):248-266. doi: 10.3934/microbiol.2017.2.248. eCollection 2017.
5
Recent Developments in Recombinant Protein-Based Dengue Vaccines.基于重组蛋白的登革热疫苗的最新进展。
Front Immunol. 2018 Aug 23;9:1919. doi: 10.3389/fimmu.2018.01919. eCollection 2018.
6
Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus.基于 nsP2 蛋白酶的无细胞高通量筛选检测法的建立,用于评估抗新兴基孔肯雅病毒抑制剂。
Sci Rep. 2018 Jul 17;8(1):10831. doi: 10.1038/s41598-018-29024-2.
7
A recombinant novirhabdovirus presenting at the surface the E Glycoprotein from West Nile Virus (WNV) is immunogenic and provides partial protection against lethal WNV challenge in BALB/c mice.一种在表面呈现来自西尼罗河病毒(WNV)E糖蛋白的重组诺如病毒在BALB/c小鼠中具有免疫原性,并能提供针对致死性WNV攻击的部分保护。
PLoS One. 2014 Mar 24;9(3):e91766. doi: 10.1371/journal.pone.0091766. eCollection 2014.